Tobacco nicotine metabolism-related transcription factor NtbHLH66 and its encoding gene, RNAi interference vector and application

By providing the NtbHLH66 gene and its RNAi interfering vector for tobacco nicotine metabolism, the problem of molecular regulation of tobacco nicotine biosynthesis has been solved, and the nicotine content has been significantly reduced, providing a new strategy for tobacco breeding and promoting low-level Development of nicotine tobacco varieties.

CN116751787BActive Publication Date: 2024-11-22ZHENGZHOU TOBACCO RES INST OF CNTC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310482239.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-29
Publication Date
2024-11-22
Estimated Expiration
2043-04-29

AI Technical Summary

Technical Problem

The prior art lacks breakthrough progress in molecular regulation of tobacco nicotine biosynthesis, especially the role of tobacco's own regulating nicotine synthesis has not been fully studied, resulting in limited multi-purpose development of tobacco.

Method used

Provide the NtbHLH66 gene, the transcription factor associated with tobacco nicotine metabolism, and its encoded RNAi interference vector, silencing the NtbHLH66 gene through RNA interference technology, reducing the nicotine content, thereby providing new gene resources for the breeding of low-nicotine tobacco varieties.

Benefits of technology

The successful acquisition of tobacco plants with NtbHLH66 gene silencing significantly reduced the nicotine content, provided new strategies and paths for nicotine content regulation in tobacco and other plants, and laid the foundation for precise breeding of low-nicotine content tobacco.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116751787B_ABST
    Figure CN116751787B_ABST
Patent Text Reader

Abstract

The present invention discloses a tobacco nicotine metabolism-related transcription factor NtbHLH66, a coding gene thereof, an RNAi interference vector and an application thereof. The tobacco nicotine metabolism-related transcription factor coding gene NtbHLH66 gene of the present invention has a nucleotide sequence as follows: (1) a nucleotide sequence shown in SEQ ID NO.1; (2) a nucleotide sequence in which the nucleotide sequence shown in SEQ ID NO.1 is replaced and / or deleted and / or one or more nucleotides are added and the nucleotide sequence expressing the same functional protein. By interfering with the expression of the tobacco NtbHLH66 gene, it is found that after silencing the NtbHLH66 gene, the nicotine content in the leaves of the NtbHLH66 gene interference strain at the seedling stage is significantly reduced compared with the control strain. The present invention provides a new strategy and path for reducing the nicotine content in tobacco, and has broad application prospects and huge economic benefit potential in the field of low-nicotine tobacco variety breeding.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a tobacco nicotine metabolism-related transcription factor NtbHLH66 and a coding gene, an RNAi interference vector and application thereof, and belongs to the technical field of bioengineering. Background Art

[0002] Alkaloids are often called plant alkaloids. They are the most widely existing secondary metabolites in plants besides terpenoids and are generally alkaline. Only a small number of plants in the plant kingdom contain alkaloids, which are mainly found in Solanaceae plants. Their biological function is mainly insect resistance. In tobacco (Nicotiana tabacum L.), there are mainly four alkaloids, namely nicotine, nornicotine, anabasine and anabasine. Among them, nicotine is the most important tobacco alkaloid, accounting for 90-95% of the total alkaloid content in cultivated tobacco. Tobacco is an important economic crop and one of the plants with the largest biomass in nature. It has great potential for exploration and utilization. However, the high nicotine content in tobacco has limited the multi-purpose development and utilization of tobacco to a considerable extent. Therefore, research on nicotine biosynthesis and regulation has long been one of the focuses in the field of secondary metabolism research.

[0003] After years of research, we have a clearer understanding of the nicotine biosynthesis pathway: ornithine decarboxylase (ODC) catalyzes ornithine or arginine decarboxylase (ADC) catalyzes arginine to produce putrescine, putrescine is catalyzed by putrescine N-methyltransferase (PMT) to produce N-methylputrescine, and N-methylputrescine is catalyzed by N-methylputrescine oxidase (MPO) to produce 4-methylbutanal; nicotinic acid or derivatives formed through the aspartate pathway can form a pyridine ring; the pyrrolidine ring formed by the natural cyclization of the pyridine ring and 4-methylbutanal condenses to form nicotine. However, there has been no breakthrough in the molecular regulation of nicotine biosynthesis. In addition to plant hormones, the role of the sites in tobacco itself that regulate nicotine synthesis needs further study.

[0004] So far, more than 10 transcription factor genes involved in nicotine synthesis have been found, belonging to different families. However, in order to further understand the molecular regulation of nicotine synthesis and achieve more precise tobacco breeding, it is an urgent problem to explore and screen the transcription factor regulatory genes involved in nicotine metabolism. Summary of the invention

[0005] The first object of the present invention is to provide a tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66, which can encode the tobacco nicotine metabolism-related transcription factor NtbHLH66.

[0006] The second object of the present invention is to provide a tobacco nicotine metabolism-related transcription factor NtbHLH66, which is closely related to tobacco nicotine synthesis and metabolism.

[0007] The third object of the present invention is to provide an RNAi interference vector, which can achieve efficient silencing of the NtbHLH66 gene, successfully obtain tobacco plants with NtbHLH66 gene silenced, and then reduce the nicotine content in the silenced strain.

[0008] The fourth object of the present invention is to provide the application of the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 gene or RNAi interference vector in the breeding of low-nicotine tobacco varieties. After silencing the NtbHLH66 gene in tobacco plants through RNAi interference technology, it was found that the nicotine content in the silenced strain was significantly reduced, providing new gene resources for the breeding of low-nicotine tobacco varieties.

[0009] In order to achieve the above object, the technical solution adopted by the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 of the present invention is:

[0010] The nucleotide sequence of the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 is:

[0011] (1) the nucleotide sequence shown in SEQ ID NO.1;

[0012] (2) A nucleotide sequence in which one or more nucleotides are replaced and / or deleted and / or added to the nucleotide sequence shown in SEQ ID NO. 1 and the nucleotide sequence expresses a protein with the same function.

[0013] The beneficial effect of the above technical solution is that: the present invention cloned the coding gene of tobacco nicotine metabolism-related transcription factor NtbHLH66 by designing specific primers, and fluorescent quantitative PCR analysis showed that in normal tobacco plants, the NtbHLH66 gene was mainly expressed in roots, stems, leaves and flower buds, especially in the roots with the highest expression level.

[0014] In order to achieve the above object, the technical solution adopted by the tobacco nicotine metabolism-related transcription factor NtbHLH66 of the present invention is:

[0015] The amino acid sequence of the tobacco nicotine metabolism-related transcription factor NtbHLH66 is:

[0016] (1) the amino acid sequence shown in SEQ ID NO.2;

[0017] (2) A derivative protein having the same function as the amino acid sequence shown in SEQ ID NO. 2, wherein one or more amino acid residues are replaced and / or deleted and / or added.

[0018] The beneficial effect of the above technical solution is that: it has been verified that the tobacco nicotine metabolism-related transcription factor NtbHLH66 of the present invention is closely related to the anabolism of nicotine in tobacco.

[0019] In order to achieve the above-mentioned purpose, the technical solution adopted by the RNAi interference vector of the present invention is:

[0020] The RNAi interference vector comprises a specific nucleotide fragment of the NtbHLH66 gene as a guide sequence.

[0021] The beneficial effect of the above technical solution is that the interference strain obtained by RNAi has a better gene silencing effect than the VIGS strain, is more stable, and can be passed on to the next generation.

[0022] As a further improvement, the nucleotide sequence of the guide sequence is shown as SEQ ID NO.3.

[0023] As a further improvement, the guide sequence was inserted into the PBWA(V)HS empty vector for screening and sequencing identification.

[0024] In order to achieve the above-mentioned object, the technical scheme adopted by the application of the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 gene or RNAi interference vector in the cultivation of tobacco low-nicotine varieties is:

[0025] Application of tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 gene or RNAi interference vector in the breeding of low-nicotine tobacco varieties.

[0026] The beneficial effect of the above technical solution is that: the present invention interferes with the expression of NtbHLH66 gene in tobacco through RNA interference silencing technology to obtain NtbHLH66 gene silenced transgenic plants. Detection found that the nicotine content in the leaves of the obtained NtbHLH66 gene silenced plants in the seedling stage was significantly reduced, which provides new strategies and paths for the molecular breeding of nicotine content regulation in tobacco and other plants, and also lays the foundation for the precise breeding of low-nicotine content tobacco.

[0027] As a further improvement, after silencing the NtbHLH66 gene, the nicotine content in tobacco leaves was significantly reduced.

[0028] As a further improvement, the low-nicotine tobacco variety is obtained by the following method: the RNAi vector is transformed into Agrobacterium as an infection liquid, and then transformed into tobacco, and the tobacco variety with significantly reduced nicotine content in leaves is obtained through screening and identification.

[0029] The beneficial effects of the above technical solution are: the gene silencing effect of the interference strain obtained by the Agrobacterium transformation method is better, and the gene silencing of the next generation is more stable.

[0030] The present invention uses real-time PCR to find that the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 is expressed in all tobacco tissues, and is relatively highly expressed in tobacco leaves, flowers and roots. To further confirm the function of the NtbHLH66 gene, an RNAi vector for silencing the NtbHLH66 gene was constructed through RNAi technology, and a silent strain that inhibits the expression of the NtbHLH66 gene was successfully obtained after transformation. The test results show that compared with the control plants, the nicotine, nornicotine and neonicotine contents in the leaves of the transgenic silenced plants are significantly reduced, indicating that the NtbHLH66 gene is highly related to the biosynthesis metabolism of tobacco alkaloids, providing an important reference for the regulation and control research of plant secondary metabolism, and laying the foundation for the cultivation of new low-nicotine plant varieties. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 This is the expression pattern analysis of the NtbHLH66 gene in Experimental Example 1 of the present invention;

[0032] Figure 2 The electrophoresis diagram of the PCR product of the NtbHLH66 gene in Experimental Example 1 of the present invention (M is a marker, lane 1 is a forward sequence PCR product, and lane 2 is a reverse sequence PCR product);

[0033] Figure 3 This is the RNAi interference vector pBWA(V)HS-RNAi map in Experimental Example 2 of the present invention;

[0034] Figure 4 This is the restriction enzyme digestion map of pBWA(V)HS-NtbHLH66-RNAi in Experimental Example 2 of the present invention (M is a marker, and lane 1 is the restriction enzyme digestion product);

[0035] Figure 5 This is the gene expression analysis of the NtbHLH66-RNAi transgenic strain NtbHLH66 in Experimental Example 3 of the present invention;

[0036] Figure 6 This is an analysis of the alkaloid content of the NtbHLH66-RNAi transgenic strain and the control K326 in Experimental Example 4 of the present invention. DETAILED DESCRIPTION

[0037] The present invention is further described in detail below in conjunction with specific examples. Unless otherwise specified, the equipment and reagents used in each embodiment, experimental example and comparative example can be obtained from commercial sources.

[0038] The tobacco NtbHLH66 gene of the present invention encodes the tobacco nicotine metabolism-related transcription factor NtbHLH66, and the amino acid sequence contained in the transcription factor is shown in SEQ ID: No. 2. The transcription factor may also be formed by replacing and / or deleting and / or adding one or more amino acid residues of the amino acid sequence shown in SEQ ID No: 2, and has a derivative polypeptide that affects tobacco nicotine accumulation. The replacement and / or deletion and / or addition of one or more amino acid residues refers to the replacement and / or deletion and / or addition of no more than 10 amino acid residues.

[0039] The nucleotide sequence contained in the gene encoding the tobacco nicotine metabolism-related transcription factor NtbHLH66 of the present invention is as shown in SEQ ID: No. 1. Or a nucleotide sequence that can hybridize with the DNA sequence defined by SEQ ID No: 1 in the sequence list under highly stringent conditions; or a DNA sequence that has more than 90% homology with the DNA sequence defined by SEQ ID No: 1 in the sequence list and encodes the same functional protein.

[0040] The application of the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 in the present invention is to inhibit the expression of the NtbHLH66 gene in tobacco plants, which can change the nicotine content of tobacco leaves at the seedling stage. The expression of the NtbHLH66 gene can be inhibited by various methods mediated by RNA, such as: plant virus vector-mediated gene silencing method, Agrobacterium-mediated transformation RNAi interference vector, optimization and modification of gene coding frame, optimization of gene promoter and the like. The method of inhibiting gene expression in the present invention is not limited to the above methods, as long as it can inhibit the expression of NtbHLH66.

[0041] All plant tissue materials in the following examples were taken from the flue-cured tobacco (Nicotiania tabacum L.) variety K326 and the K326 transgenic plants of RNAi interference NtbHLH66. The tobacco materials were planted in an artificial climate chamber, the growth temperature was 25°C, and the photoperiod was 12 hours of light / 12 hours of darkness. Leaves were collected from tobacco seedlings, quick-frozen in liquid nitrogen, and used for subsequent molecular experiments; leaves were collected and freeze-dried for subsequent metabolic detection.

[0042] Example 1 of the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 gene

[0043] The nucleotide sequence of the tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 in this example is:

[0044] (1) the nucleotide sequence shown in SEQ ID NO.1;

[0045] (2) A nucleotide sequence in which one or more nucleotides are replaced and / or deleted and / or added to the nucleotide sequence shown in SEQ ID NO. 1 and the nucleotide sequence expresses a protein with the same function.

[0046] Example 1 of tobacco nicotine metabolism-related transcription factor NtbHLH66

[0047] The amino acid sequence of the tobacco nicotine metabolism-related transcription factor NtbHLH66 in this example is:

[0048] (1) the amino acid sequence shown in SEQ ID NO.2;

[0049] (2) A derivative protein having the same function as the amino acid sequence shown in SEQ ID NO. 2, wherein one or more amino acid residues are replaced and / or deleted and / or added.

[0050] Example 1 of RNAi interference vector

[0051] The RNAi interference vector of this example comprises a specific nucleotide fragment of the NtbHLH66 gene as a guide sequence, and the nucleotide sequence of the guide sequence is shown in SEQ ID NO.3.

[0052] Example 1 of application of tobacco nicotine metabolism-related transcription factor encoding gene NtbHLH66 gene or RNAi interference vector in cultivation of low-nicotine tobacco varieties

[0053] In this example, tobacco plants were transformed with an RNAi interference vector containing a specific nucleotide fragment of the NtbHLH66 gene to construct tobacco plants with NtbHLH66 gene silencing. The nicotine, nornicotine and neonicotine contents in the leaves of this strain were significantly reduced, and a tobacco variety with a low nicotine content was obtained.

[0054] Experimental Example 1 Analysis of the expression pattern of NtbHLH66 gene and cloning of NtbHLH66 gene fragment

[0055] 1. Extraction of tobacco RNA

[0056] The roots, stems, leaves and flowers of cultivated tobacco K326 grown to the seedling stage were used as samples. After being fully ground into powder by liquid nitrogen, about 100 mg of the powdered material was placed in a 1.5 ml centrifuge tube containing 1.0 ml TRIZOL reagent, 200 μl of chloroform was added, and the mixture was shaken and mixed. After centrifugation, the upper aqueous phase was carefully removed and transferred to another centrifuge tube, 500 μl of isopropanol was added, and RNA was separated by precipitation and centrifugation. It was then washed with 75% alcohol, slightly dried at room temperature, and an appropriate volume of RNase free water was added to fully dissolve it. The extracted total RNA was treated with DNase I, and the digestion reaction system is shown in Table 1.

[0057] Table 1 Reaction system of DNase I digestion

[0058] Composition Dosage RNA 1 μg 10×reaction buffer with MgCl2 1μl DNase I, RNase-free 1μl(1U) DEPC-treated water to 10μl

[0059] The reaction conditions were 37°C in a water bath for 30 min.

[0060] 2. cDNA Synthesis

[0061] Prepare the template RNA / primer mixture in Table 2 in a sterile 0.2 ml centrifuge tube, keep it at 70°C for 10 min, then quickly cool it on ice for more than 2 min, and centrifuge it for a few seconds to allow the denatured solution of the template RNA / primer to accumulate at the bottom of the centrifuge tube.

[0062] Table 2 RNA / primer mixture preparation

[0063] name Dosage RNA (100 ng / μl) 1μl Oligo(dT)Primer(50μM) 1μl <![CDATA[RNase free dH2O]]> 5μl Total Volume 7μl

[0064] After preparing the reverse transcription reaction solution in Table 3 in the above centrifuge tube, incubate at 42°C for 1 hour; incubate at 70°C for 15 minutes and then cool on ice. The obtained cDNA is used for PCR amplification.

[0065] Table 3 Reverse transcription reaction solution preparation

[0066] Reagent name Dosage The above template RNA / primer denaturation solution 7μl 5×M-MLV buffer 2μl dNTP Mixture (10 mM each) 0.5μl RNase Inhibitor (40U / μl) 0.25μl RTase M-MLV(RNase H-)(200U / μl) 0.25μl Total Volume 10μl

[0067] 3. Analysis of the expression pattern of NtbHLH66 gene in different tissues and organs of tobacco

[0068] Using K326 cDNA as a template, the expression of NtbHLH66 gene in various tissues and organs was detected by real-time quantitative PCR. Using tobacco 26S gene as an internal reference, fluorescence quantitative PCR detection was performed, and the primer sequences were as follows:

[0069] The detection primers and internal reference primers are shown below.

[0070] qRT-PCR primers are:

[0071] q NtbHLH66-F: 5'-CAATAAGACGGACAAGGC-3' (as shown in SEQ ID NO. 4);

[0072] q NtbHLH66-R: 5′-CCACCCAATCTACTCATACTC-3′ (as shown in SEQ ID NO. 5).

[0073] The internal reference gene primers are:

[0074] 26s-F: 5'-GAAGAAGGTCCCAAGGGTTC-3' (as shown in SEQ ID NO. 6);

[0075] 26s-R: 5'-TCTCCCTTTAACACCAACGG-3' (as shown in SEQ ID NO. 7).

[0076] Test results such as Figure 1 As shown in the figure, it can be seen that in normal tobacco plants, the NtbHLH66 gene is mainly expressed in roots, stems, leaves and flower buds, especially in the roots with the highest expression level.

[0077] 4. Cloning of NtbHLH66 gene

[0078] Using K326 cDNA as a template and primers designed according to the tobacco genome database information, PCR amplification of the NtbHLH66 gene was performed to obtain a PCR amplification product.

[0079] Primers for amplifying the forward NtbHLH66 gene fragment:

[0080] NtbHLH66-F: 5'-cagtGGTCTCacaacgccatgaaccagtacgatcc-3' (as shown in SEQ ID NO. 8);

[0081] NtbHLH66-R: 5′-cgatGGTCTCacctgcaggtgctgaagaggattag-3′ (as shown in SEQ ID NO. 9).

[0082] LOOP Primer:

[0083] F: 5'-cgatGGTCTCacaggtctagtttttctcctt-3' (as shown in SEQ ID NO. 10);

[0084] R: 5'-cgatGGTCTCagcccgggctctgtaactatc-3' (as shown in SEQ ID NO. 11).

[0085] Primers for amplification of the reverse NtbHLH66 gene fragment:

[0086] NtbHLH66-F: 5'-cagtGGTCTCagggctgctgaagaggattagaagg-3' (as shown in SEQ ID NO. 12);

[0087] NtbHLH66-R: 5′-cagtGGTCTCatacagccatgaaccagtacgatcc-3′ (as shown in SEQ ID NO. 13).

[0088] The PCR amplification system is shown in Table 4, and the reaction procedure is shown in Table 5.

[0089] Table 4 PCR amplification system

[0090] Reagent name Dosage GXL polymerase 1μl 5×GXL buffer 10μl dNTP Mixture (10mM) 4μl Primer-F / R 8μl <![CDATA[ddH2O]]> 26μl cDNA 1μl Total Volume 50μl

[0091] Table 5 PCR reaction program

[0092]

[0093] The PCR products obtained by amplification were electrophoresed on 1% agarose gel. Figure 2 After electrophoresis, the PCR product of 200 bp was recovered and purified using the Takara PCR product purification kit according to the product instructions, and sent to Shanghai Bioengineering for sequencing to verify the sequence results.

[0094] Experimental Example 2 Construction of RNAi vector

[0095] 1. Connect

[0096] After the PCR product containing the Infusion linker sequence obtained in Example 1 was purified, the target fragment was ligated into the pBWA(V)HS-RNAi vector using the Infusion ligase. The pBWA(V)HS-RNAi vector is shown in FIG. Figure 3 The infusion connection system is shown in Table 6.

[0097] Table 6 Infusion connection system

[0098] name Dosage 5×Infusion Ligase 2μl pBWA(V)HS-RNAi after restriction digestion 2μl Gene fragment 6μl Total Volume 10μl

[0099] The fragment mixture was reacted at 50°C for 15 minutes and then placed on ice for 2-3 minutes.

[0100] 2. Heat shock transformation

[0101] Under sterile conditions, take 10μl of the ligation product and add it to the competent E. coli cells, mix gently and place on ice for 30 minutes. Heat shock at 42℃ for 90 seconds, and quickly transfer the centrifuge tube to an ice bath for 2-3 minutes. Add 800μl of LB medium without antibiotics, shake gently at 37℃ (100-160rpm) for about 1 hour. Take 200μl of the culture solution and apply it on the LB solid medium containing 50μg / ml of antibiotics. Before applying the bacterial solution, first add X-Gal and IPTG and spread evenly, and invert and culture at 37℃ for 12-16 hours.

[0102] 3. Screening and identification of positive clones

[0103] Many blue and white plaques grow in the culture medium. When the plaques grow to a suitable size, pick a few white spots with a sterilized pipette tip and culture them in LB liquid culture medium containing 50μg / ml kanamycin for 12-16h with shaking. Figure 4 As shown, there are three clear bands after restriction digestion, the target sequence size is 1100 bp, and the RNA vector is successfully constructed. The RNAi vector with correct restriction digestion identification is retained and named pBWA(V)HS-NtbHLH66-RNAi.

[0104] Experimental Example 3 Agrobacterium-mediated tobacco transformation and identification of transgenic plants

[0105] 1. Freeze-thaw transformation of Agrobacterium

[0106] Add 1 μg of pBWA(V)HS-NtbHLH66-RNAi vector to 100 μEHA105 Agrobacterium L competent cells, mix well, let stand on ice for 30 min, freeze in liquid nitrogen for 5 min, then take out from liquid nitrogen, put in a 37°C water bath for 5 min, let stand on ice for 5 min, add 500 μl of LB solution, resume culture at 28°C with sufficient shaking for 4 h, finally spread the bacterial solution evenly on the selective plate culture medium and culture at 28°C for 24-48 h.

[0107] 2. Leaf disc method for tobacco plant transformation

[0108] The present invention uses the leaf disc method to transform the RNAi vector successfully constructed in Example 2 into K326 tobacco, and the specific implementation operation is as follows:

[0109] (a) Under sterile conditions, tobacco K326 seeds were placed in EP tubes and rinsed with sterile water for 2-3 times; then, they were soaked in 75% alcohol for 30-60 seconds, treated with 0.1% mercuric chloride for 5 minutes, rinsed with sterile water for 5 times, and sown on MS culture medium. The culture bottles were placed in an artificial climate chamber to ensure normal germination and growth of tobacco seedlings.

[0110] (b) When the tobacco seedlings grow to 3-5cm (about 20-30 days), take the top buds and place them on MS+BA 0.2mg / L (strong buds, rapid growth) medium for subculture. After 14 days of subculture (small leaves are OK), take leaves, 1cm×1cm in size, cut off the petiole, scratch the surface and edge of the leaves, and place them on MS+BA 1.0mg / L pH 6.0-6.5 pre-culture medium, face down and close to the medium, and pre-culture in the dark for 2-3 days.

[0111] (c) Take out the pre-cultured leaves or stem segments and place them in the Agrobacterium infection solution for infection. The night before infection, shake two bottles of Agrobacterium. Fill a 2mL centrifuge tube with the bacterial solution, centrifuge at 4000r / min for 5 minutes, and wash twice with the suspension solution. Add the suspension solution at a ratio of 1:10 (10mL of suspension solution to 1 tube of 1.5mL of bacteria), add 25mg / L of acetosyringone (As), and shake the infection solution continuously to make it fully contact with the cut of the leaves and stem segments. After 15 minutes, take it out and place it on sterilized dry filter paper to absorb the bacterial solution.

[0112] The preparation method of Agrobacterium infection solution is as follows: take transformed Agrobacterium stored in a -80°C refrigerator, streak plate culture, add 50mg / L Kan and 50mg / L Rif to the LB solid plate; pick a single bacterial plaque to 5mL LB liquid culture medium containing 50mg / L Kan and 50mg / L Rif, put it in a shaker at 28°C and 200r / min for overnight culture (12-16h); when the bacterial solution concentration reaches about OD600=1.5, take 2mL of bacterial solution and add it to a centrifuge tube, centrifuge at 4000r / min for 5min; remove the supernatant, aspirate 1mL of new MS liquid culture medium, resuspend Agrobacterium, and centrifuge at 4000r / min for 5min; repeat step (6) once; resuspend the bacteria with 1mL of MS liquid culture medium, and then add it to 40mL of MS liquid culture medium (containing 40μL 25mg / L As), which is the infection solution. Infect after leaving it for 2h.

[0113] 200 mL of bacterial suspension was prepared as follows:

[0114] 100× 2mL of macronutrient solution (NH4NO3 165g / L, KNO3 190g / L, MgSO4·7H2O 37g / L, KH2PO4 17g / L, CaCl2·2H2O 44g / L)

[0115] 100× organic element mother solution 2ml (inositol 10g / L, niacin 0.05g / L, pyridoxine hydrochloride 0.05g / L, nicotinic acid thiamine 0.01g / L, glycine 0.2g / L)

[0116] 100× Iron salt stock solution 2mL (Disodium EDTA, 37.3mg / L, FeSO4·7H2O 27.8mg / L)

[0117] 100× trace element mother solution 2mL (MnSO4·4H2O 22.3mg / L, ZnSO4·7H2O 8.6mg / L, CoCl2·6H2O0.025mg / L, CuSO4·5H2O 0.025mg / L, Na2MoO4·2H2O 0.25mg / L, KI 0.83mg / L, H3BO36.2mg / L)

[0118] Sucrose 5.6g

[0119] Add deionized water to make up to 200 mL.

[0120] (d) The leaves and stem segments were placed back on the pre-culture medium and co-cultured at 28°C in the dark for 2-3 days until micro-bacterial plaques were formed around the leaf cuts; the co-cultured tobacco leaves and stem segments were taken out and rinsed 6 times with sterile water supplemented with 500 mg / L Cef, and the first time was placed on a shaker for 30 minutes, and the next time was 5 minutes, so as to wash away the Agrobacterium on the surface of the explants;

[0121] (e) Blot dry with filter paper and transfer to tobacco budding medium, which is MS+BA 1.0mg / L+Hyg 25mg / L+Cef 500mg / L pH 5.8; observe after 2 weeks. If no bacteria grow, reduce the Cef concentration. If bacteria grow, continue to maintain the Cef concentration.

[0122] (f) Replace the culture medium every 2 weeks until adventitious buds grow (usually 2 weeks). Cut the regenerated seedlings (about 1 cm) and transfer them to the subculture medium MS + BA 0.2-0.1 mg / L + Hyg 25 mg / L + Cef 500 mg / L pH 5.8; when the seedlings grow to 2 cm long (small buds are OK), transfer them to the rooting medium MS + NAA 0.2-0.1 mg / L, 25°C, 12h light, and culture for about 3 weeks to grow strong roots.

[0123] (g) When the roots grow to 2-3 cm and the seedlings are about 7-10 cm tall, remove the flask, wash off the root culture medium, and transplant them into pots for greenhouse cultivation.

[0124] 3. Identification of transgenic plants

[0125] The genomic DNA of transgenic tobacco seedlings was extracted using the DNA extraction kit of Takara Company. The Kan resistance gene primers were designed for PCR amplification and positive plants were screened. Ten positive plants were detected.

[0126] Kan resistance gene primers are:

[0127] Kan-F: 5'-TCTGGACGAAGAGCATCAGG-3' (as shown in SEQ ID NO. 14);

[0128] Kan-R: 5'-ATGAATCCAGAAAAGCGGCC-3' (as shown in SEQ ID NO. 15).

[0129] RNA was extracted from wild-type K326 tobacco and three NtbHLH66-RNAi transgenic tobacco lines and cDNA was synthesized according to the method described in Example 1. Fluorescence quantitative PCR was used to detect the expression of NtbHLH66 in different transgenic lines. The detection primers and internal reference primers were as described in Example 1.

[0130] Test results such as Figure 5 As shown in the figure, it can be seen that the RNAi interference vector constructed by the present invention can effectively interfere with the expression of the NtbHLH66 gene. The transgenic strain with the lowest expression (RNAi2) was selected as the research object, and the nicotine content of the leaves was detected to verify the function of the NtbHLH66 gene.

[0131] Experimental Example 4 Determination of alkaloid content in tobacco leaves

[0132] Cultivated tobacco K326 plants and transgenic tobacco seeds of RNAi interference transgenic lines were evenly sown in small pots containing nutrient soil and cultured in a light culture room. At the seedling stage, the leaves were quickly frozen in liquid nitrogen and freeze-dried in a freeze dryer. Weigh 0.3g of freeze-dried fresh leaf powder into a 50mL screw-capped pressure test tube, add 2.5mL of 5% sodium hydroxide solution, moisten the sample, let it stand for 15 minutes, add 20mL of 0.01% triethylamine / methyl tert-butyl ether solution, cover and seal, place in an ultrasonic generator for ultrasonic extraction at room temperature for 15 minutes, and then centrifuge at 6000r / min for 5 minutes. Take 2mL of organic phase for GC / MS analysis to detect the nicotine content; accurately transfer 10mL of organic phase to concentrate to 1mL, and perform GC / MS analysis to detect the content of the other 10 alkaloids. The detection of nicotine and the other 10 alkaloids was completed in two injections, using retention time and selected ion (SIM) mode for qualitative analysis and double internal standard for quantitative analysis. The test results are as follows Figure 6 As shown in the figure, it can be seen that after silencing the NtbHLH66 gene, the contents of nicotine, nornicotine and neonicotinoid in the leaves of NtbHLH66-RNAi transgenic tobacco plants were significantly reduced.

[0133] Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. Silencing genes encoding transcription factors related to tobacco nicotine metabolism NbH66 The application of the gene in the breeding of low-nicotine tobacco varieties is characterized by: Will NbH66 After gene silencing, the nicotine content in tobacco leaves was significantly reduced; NbH66 The nucleotide sequence of the gene is shown in SEQ ID NO.

1.

2. Silencing genes encoding transcription factors related to tobacco nicotine metabolism NbH66 The application of the RNAi interference vector of a gene in the breeding of low-nicotine tobacco varieties is characterized by: Said NbH66 The nucleotide sequence of the gene is shown in SEQ ID NO.1; the RNAi interference vector comprises NbH66 The specific nucleotide fragment of the gene is the guide sequence.

3. The silencing tobacco nicotine metabolism-related transcription factor encoding gene according to claim 2 NbH66 The application of the RNAi interference vector of a gene in the breeding of low-nicotine tobacco varieties is characterized by: The nucleotide sequence of the guide sequence is shown in SEQ ID NO.

3.

4. The silencing tobacco nicotine metabolism-related transcription factor encoding gene according to claim 2 or 3 NbH66 The application of the RNAi interference vector of a gene in the breeding of low-nicotine tobacco varieties is characterized by: The low-nicotine tobacco variety is obtained by the following method: the RNAi interference vector is transformed into Agrobacterium as an infection liquid, and then the tobacco is transformed, and the tobacco variety with significantly reduced nicotine content in the leaves is obtained through screening and identification.